Following the European Commission’s draft proposal for implementing the so-called SPC manufacturing waiver the Committee on Legal Affairs of the European Parliament published a draft report on presenting its suggested...more
1/15/2019
/ EU ,
European Commission ,
European Parliament ,
Generic Drugs ,
Intellectual Property Protection ,
Life Sciences ,
Manufacturers ,
Marketing Perspectives ,
Patent Expiration ,
Patent Infringement ,
Patents ,
Pharmaceutical Industry ,
Regulatory Requirements ,
Supplementary Protection Certificate ,
Waivers
Increasing competition within Europe’s pharmaceutical space makes knowing the market and understanding available patent protections more critical than ever for both well established and new market players. Andreas von Falck...more
5/18/2018
/ Biotechnology ,
Compulsory Licenses ,
Doctrine of Equivalents ,
EU ,
Generic Drugs ,
Injunctions ,
Intellectual Property Protection ,
Inventions ,
Litigation Strategies ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Popular ,
Prescription Drugs ,
Technology Sector
The X. Civil Senate of the German Federal Court of Justice has granted a motion by three companies of the Merck Sharp & Dohme group (Merck) for a preliminary permission for the continued distribution of Isentress®, a drug...more
7/18/2017
/ AIDS ,
Compulsory Licenses ,
Drug Distribution ,
Germany ,
HIV ,
Merck ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prescription Drugs ,
Public Health